Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages.
BACKGROUND
The cause of corticosteroid-resistant (CR) asthma is unknown.


OBJECTIVE
We sought to perform gene microarray analyses by using bronchoalveolar lavage (BAL) cells from well-characterized subjects with CR asthma and subject with corticosteroid-sensitive (CS) asthma to elucidate the differential expression of genes that contribute to the development of corticosteroid resistance.


METHODS
The patients were characterized as having CR or CS asthma based on FEV(1) percent predicted improvement after a 1-week course of oral prednisone. Expression of selected gene targets was verified by means of real-time PCR and ELISA.


RESULTS
Microarray analyses demonstrated significantly higher levels (>3-fold increase, P < .05) of transcripts for TNF-alpha, IL-1 alpha, IL-1 beta, IL-6, CXCL1, CXCL2, CXCL3, CXCL8 (IL-8), CCL3, CCL4, and CCL20 in BAL cells of subjects with CR asthma. These findings, confirmed by means of RT-PCR in additional BAL samples, were consistent with classical macrophage activation by bacterial products. In contrast, markers of alternatively activated macrophages, arginase I and CCL24, were decreased. Genes associated with activation of the LPS signaling pathway (early growth response 1, dual-specificity phosphatase 2, molecule possessing ankyrin repeats induced by LPS, and TNF-alpha-induced protein 3) were significantly increased in BAL samples from subjects with CR asthma (P < .05). These patients had significantly higher amounts (1444.0 +/- 457.3 pg/mg total protein) of LPS in BAL fluid than seen in subjects with CS asthma (270.5 +/- 216.0 pg, P < .05), as detected by using the LAL assay and confirmed by means of gas chromatographic/mass spectrometric analysis. Prolonged exposure to LPS induced functional steroid resistance to dexamethasone in normal human monocytes, as demonstrated by persistently increased IL-6 levels in the presence of dexamethasone.


CONCLUSIONS
Classical macrophage activation and induction of LPS signaling pathways along with high endotoxin levels detected in BAL fluid from subjects with CR asthma suggest that LPS exposure might contribute to CR asthma.
Goleva
Elena
E
Department of Pediatrics, National Jewish Health, Denver, CO 80206, USA.
Hauk
Pia J
PJ
Hall
Clifton F
CF
Liu
Andrew H
AH
Riches
David W H
DW
Martin
Richard J
RJ
Leung
Donald Y M
DY
D001249:Asthma / Q000188:drug therapy / Q000235:genetics / Q000276:immunology*; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology / Q000276:immunology; D002478:Cells, Cultured; D016207:Cytokines / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D003907:Dexamethasone / Q000494:pharmacology; D004351:Drug Resistance / Q000235:genetics; D020869:Gene Expression Profiling; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D015850:Interleukin-6 / Q000096:biosynthesis; D008070:Lipopolysaccharides / Q000032:analysis / Q000276:immunology*; D008262:Macrophage Activation; D008264:Macrophages / Q000276:immunology / Q000378:metabolism; D009000:Monocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D020411:Oligonucleotide Array Sequence Analysis; D011241:Prednisone / Q000627:therapeutic use*
D016207:Cytokines; D005938:Glucocorticoids; D015850:Interleukin-6; D008070:Lipopolysaccharides; D003907:Dexamethasone; D011241:Prednisone
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15858-63
17898169
J Allergy Clin Immunol. 2003 Dec;112(6):1195-202
14657882
Blood. 2001 Sep 1;98(5):1429-39
11520792
Br Med Bull. 2000;56(4):1054-70
11359637
FEBS Lett. 2000 Nov 17;485(1):53-6
11086164
Am J Respir Crit Care Med. 2005 Dec 1;172(11):1371-7
16141442
J Clin Invest. 2003 Jun;111(12):1863-74
12813022
J Allergy Clin Immunol. 2005 Aug;116(2):384-9
16083794
Clin Exp Allergy. 1991 Jul;21(4):441-8
1913267
Curr Opin Pulm Med. 2007 Jan;13(1):19-23
17133120
J Allergy Clin Immunol. 2007 Feb;119(2):405-13
17291857
J Leukoc Biol. 1996 Jul;60(1):8-26
8699127
Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1641-6
8970348
N Engl J Med. 2006 Feb 16;354(7):697-708
16481637
J Allergy Clin Immunol. 2002 Mar;109(3):379-92
11897980
J Immunol. 2003 Sep 15;171(6):3262-9
12960356
N Engl J Med. 2007 Oct 11;357(15):1487-95
17928596
J Allergy Clin Immunol. 2003 Jan;111(1):3-22; quiz 23
12532089
Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1600-4
10228133
J Exp Med. 1992 Jul 1;176(1):287-92
1613462
Biochem Biophys Res Commun. 2003 Apr 4;303(2):586-93
12659860
Ann Allergy Asthma Immunol. 2001 Dec;87(6):501-5
11770698
Am Rev Respir Dis. 1987 Jul;136(1):225-44
3605835
Nat Rev Immunol. 2003 Jan;3(1):23-35
12511873
J Allergy Clin Immunol. 2002 Mar;109(3):410-8
11897984
Am J Respir Crit Care Med. 2008 Jan 15;177(2):148-55
17947611
J Clin Invest. 1994 Jan;93(1):33-9
8282803
J Exp Med. 1997 Nov 3;186(9):1567-74
9348314
Am J Respir Crit Care Med. 2006 Mar 15;173(6):607-16
16387802
J Allergy Clin Immunol. 2001 May;107(5):790-6
11344344
J Cell Biochem. 2003 Aug 15;89(6):1206-14
12898518
J Allergy Clin Immunol. 2002 Nov;110(5 Suppl):S141-219
12542074
Gene. 2004 Nov 10;342(1):137-43
15527973
J Immunol. 1989 Dec 1;143(11):3673-9
2511247
J Biol Chem. 1997 Jul 11;272(28):17795-801
9211933
Trends Immunol. 2002 Nov;23(11):549-55
12401408
J Environ Monit. 2005 Dec;7(12):1371-7
16307099
Thorax. 2005 Dec;60(12):1012-8
16166100
Nat Rev Immunol. 2004 Jul;4(7):499-511
15229469
J Immunol. 2002 Apr 1;168(7):3557-62
11907119
Am Rev Respir Dis. 1987 Oct;136(4):1066
3662229
Eur Respir J. 1996 Apr;9(4):636-42
8726924
Pediatr Allergy Immunol. 1997 Aug;8(3):121-6
9532251
Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14789-94
16203992
Chest. 2004 Feb;125(2 Suppl):52S-60S; quiz 60S-61S
14872001
Am J Ind Med. 2006 Apr;49(4):296-300
16550568
J Allergy Clin Immunol. 2006 Mar;117(3):522-43
16522450
Am J Respir Crit Care Med. 2007 Apr 1;175(7):649-54
17384326
Chest. 2007 Dec;132(6):1962-6
18079229
Am J Respir Crit Care Med. 2002 Jan 15;165(2):195-9
11790654